Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H29NO2 |
Molecular Weight | 315.4498 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@]12CCN(CC3(O)CC3)[C@H](CC4=CC=C(O)C=C14)C2(C)C
InChI
InChIKey=ZDXGFIXMPOUDFF-XLIONFOSSA-N
InChI=1S/C20H29NO2/c1-4-20-9-10-21(13-19(23)7-8-19)17(18(20,2)3)11-14-5-6-15(22)12-16(14)20/h5-6,12,17,22-23H,4,7-11,13H2,1-3H3/t17-,20+/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16007240
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16007240
Bremazocine, a kappa-opioid agonist has limited potential as a clinical analgesic, however, possesses a possible utility for the therapy of alcohol and drug addiction. It was shown that bremazocine-like drugs could lower intraocular pressure and to minimize ischemic damage, that could be used in the therapy of glaucoma and cardiovascular disease.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P41145 Gene ID: 4986.0 Gene Symbol: OPRK1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16007240 |
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes. | 1990 Nov |
|
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. | 1993 Jul 15 |
|
Differential effects of fedotozine compared to other kappa agonists on diuresis in rats. | 1996 Dec |
|
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. | 1998 Mar |
|
G-protein-coupled receptor heterodimerization modulates receptor function. | 1999 Jun 17 |
|
Interactions between kappa opioid agonists and cocaine. Preclinical studies. | 2000 |
|
Pharmacological effects of naltriben as a ligand for opioid mu and kappa receptors in rat cerebral cortex. | 2001 Feb 2 |
|
Kappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity. | 2001 Jul |
|
Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists. | 2001 Oct-Dec |
|
Quantitative autoradiographic mapping of opioid receptors in the brain of delta-opioid receptor gene knockout mice. | 2002 Jul 26 |
|
Sex and rat strain determine sensitivity to kappa opioid-induced antinociception. | 2002 Mar |
|
Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice. | 2002 Nov |
|
The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway. | 2002 Nov 1 |
|
Comparison of the discriminative and neuroendocrine effects of centrally penetrating kappa-opioid agonists in rhesus monkeys. | 2002 Oct |
|
Effect of bremazocine, a kappa-opioid receptor agonist, on inositol phosphate formation in isolated iris-ciliary bodies. | 2002 Oct |
|
Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. | 2003 Aug 22 |
|
Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception. | 2003 Dec |
|
Involvement of glutamate and gamma-amino-butyric acid receptor systems on gastric acid secretion induced by activation of kappa-opioid receptors in the central nervous system in rats. | 2003 Mar |
|
Purification and mass spectrometric analysis of the mu opioid receptor. | 2003 Oct 21 |
|
Peripheral selectivity and apparent efficacy of dynorphins: comparison to non-peptidic kappa-opioid agonists in rhesus monkeys. | 2004 Apr |
|
Kappa-opioid receptors are differentially labeled by arylacetamides and benzomorphans. | 2004 Feb 6 |
|
Variable modulation of opioid brain uptake by P-glycoprotein in mice. | 2004 Jan 15 |
|
A novel and facile preparation of bremazocine enantiomers through optically pure N-norbremazocines. | 2004 Jan 2 |
|
Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine. | 2004 Jun 28 |
|
Differential effects of bremazocine on oral phencyclidine (PCP) self-administration in male and female rhesus monkeys. | 2004 May |
|
Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility. | 2004 May |
|
BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism. | 2005 Feb 21 |
|
Reciprocal regulation of agonist and inverse agonist signaling efficacy upon short-term treatment of the human delta-opioid receptor with an inverse agonist. | 2005 Jan |
|
Purification and mass spectrometric analysis of the delta opioid receptor. | 2005 May 20 |
|
Interaction of bivalent ligand KDN21 with heterodimeric delta-kappa opioid receptors in human embryonic kidney 293 cells. | 2005 Oct |
|
Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. | 2005 Summer |
|
Characterization of opioid-binding sites in zebrafish brain. | 2006 Feb |
|
Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonists. | 2006 Nov |
|
New kappa opioid receptor from zebrafish Danio rerio. | 2006 Sep 11 |
|
Aqueous humor dynamics in monkeys in response to the kappa opioid agonist bremazocine. | 2007 |
|
Selectivity of delta- and kappa-opioid ligands depends on the route of central administration in mice. | 2007 Jul |
|
Biological targets for isatin and its analogues: Implications for therapy. | 2007 Jun |
|
Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption. | 2008 Aug 15 |
|
Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats. | 2008 Jan |
|
The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors. | 2008 Jul |
|
Engineered G-protein Coupled Receptors are Powerful Tools to Investigate Biological Processes and Behaviors. | 2009 |
|
Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates. | 2009 Jan |
|
Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor. | 2009 Sep |
|
Standard opioid agonists activate heteromeric opioid receptors: evidence for morphine and [d-Ala(2)-MePhe(4)-Glyol(5)]enkephalin as selective μ-δ agonists. | 2010 Feb 17 |
|
A new synthesis of 2,3-di- or 2,3,3-trisubstituted 2,3-dihydro-4-pyridones by reaction of 3-ethoxycyclobutanones and N-p-toluenesulfonyl imines using titanium(IV) chloride: synthesis of (+/-)-bremazocine. | 2010 Jul 16 |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
ISF76M2DBE
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
PRIMARY | |||
|
100000088642
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
PRIMARY | |||
|
443406
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
PRIMARY | |||
|
71990-00-6
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
SUPERSEDED | |||
|
CHEMBL350384
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
PRIMARY | |||
|
Bremazocine
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
PRIMARY | |||
|
83829-76-9
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
PRIMARY | |||
|
C91041
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
PRIMARY | |||
|
4849
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
PRIMARY | |||
|
C027248
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
PRIMARY | |||
|
DTXSID50868536
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
PRIMARY | |||
|
SUB05884MIG
Created by
admin on Fri Dec 15 17:24:32 GMT 2023 , Edited by admin on Fri Dec 15 17:24:32 GMT 2023
|
PRIMARY |
ACTIVE MOIETY